← Leaderboards
Vincent Tam
Temple Univ Of The Commonwealth
$2,030,604
Attributed
$2,030,604
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $409.7K · FY2019–25$500K$375K$250K$125K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,030,604 · 2
By mechanism
R01$1,594,729 · 1
R21$435,875 · 1
Top collaborators
No co-investigators on record.
Most similar at Temple Univ Of The Commonwealth
Same institution · by research overlap
- Slava Rom$2,155,160
- Nicholas Lyssenko$1,771,516
- Roy H. Stevens$420,366
- Cagla Tukel$7,123,611
Others in their field
Other Emerging Leaders on “Influenza”
- Ted Ross · University Of Georgia$71,962,304
- Tony Moody · Duke University$65,625,959
- Matthew Johnson · Duke University$61,899,930
- Scott Hensley · University Of Pennsylvania$44,549,615
- Stuart Hellyar Hellyar$34,175,230
- Beth Baseler · Leidos Biomedical Research, Inc.$30,337,006
Research focus
InfluenzaInflammatory ResponseImmune SystemImmune SignalingInfectionInflammatoryHomeostasisImmuneEicosanoidsImmune ResponseImmunologicsImmunotherapeutic AgentCellsInflammationAffectGenetic TranscriptionCessation Of LifeHuman DiseaseAnti-Bacterial AgentsClinically RelevantBacterial InfectionsComplicationGeneticInsight
Grant awards (6)
The Role of Eicosanoid-PPAR axis in Exacerbating Post-Influenza Staphylococcus aureus Super-infection$394,974
R01 · FY2025 · AI · contact PI
The Role of Eicosanoid-PPAR axis in Exacerbating Post-Influenza Staphylococcus aureus Super-infection$395,008
R01 · FY2024 · AI · contact PI
The Role of Eicosanoid-PPAR axis in Exacerbating Post-Influenza Staphylococcus aureus Super-infection$395,044
R01 · FY2023 · AI · contact PI
The Role of Eicosanoid-PPAR axis in Exacerbating Post-Influenza Staphylococcus aureus Super-infection$409,703
R01 · FY2022 · AI · contact PI
Anti-inflammatory bioactive lipids exacerbating Staphylococcus aureus infection post influenza$198,125
R21 · FY2020 · AI · contact PI
Anti-inflammatory bioactive lipids exacerbating Staphylococcus aureus infection post influenza$237,750
R21 · FY2019 · AI · contact PI